Associate Professor of Clinical Pathology and Laboratory Medicine
Ely, Scott Adams
(212) 746-2442 (212) 746-8173
Dr. Ely's practice in hematopathology mainly involves the diagnosis of and prognostication for multiple myeloma (MM), lymphoma and leukemias. His research has been in the areas of B cell lymphomas and plasma cell neoplasms (MM and monoclonal gammopathy of undetermined significance [MGUS]). Dr. Ely is co-director of the immunopathology core for the Specialized Center of Research for Multiple Myeloma. As such, his main research focus is developing assays for cell cycle analysis at the single cell level, through the use of manual and automated quantitative image analysis of immunohistochemistry. His work applies mainly on the use of such assays for drug development and efficacy monitoring in multiple myleoma and lymphoma patients. Through the utilization of these assays, his work has helped in our understanding of the role of the cell cycle in these and other cancers, and it has led directly to the development of targeted therapies. Although development of these assays is ongoing, currently they are being used in 4 multi-center phase 1/2 clinical trials.
(212) 746-2442 
(212) 746-8173
Back to Top